Cargando…

A Study on Weight Loss Cause as per the Side Effect of Liraglutide

PURPOSE: Liraglutide is known to have much lower weight loss effects in real clinical fields than in randomized clinical trials because of its side effects (SE) and discomfort associated with injections. This study is aimed at determining whether the side effects of liraglutide affect weight reducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jin, Lee, Jeongmin, Lee, Seung-Hwan, Cho, Jae-Hyung, Kim, Hun-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733986/
https://www.ncbi.nlm.nih.gov/pubmed/36540096
http://dx.doi.org/10.1155/2022/5201684
_version_ 1784846492645720064
author Yu, Jin
Lee, Jeongmin
Lee, Seung-Hwan
Cho, Jae-Hyung
Kim, Hun-Sung
author_facet Yu, Jin
Lee, Jeongmin
Lee, Seung-Hwan
Cho, Jae-Hyung
Kim, Hun-Sung
author_sort Yu, Jin
collection PubMed
description PURPOSE: Liraglutide is known to have much lower weight loss effects in real clinical fields than in randomized clinical trials because of its side effects (SE) and discomfort associated with injections. This study is aimed at determining whether the side effects of liraglutide affect weight reduction and its maintenance in real-world practice. METHODS: Endocrinologists conducted a retrospective chart review of data from two tertiary university hospitals. All patients who had been prescribed liraglutide at least once between January 2014 and December 2019 were included. For an average of 3 and 6 months, weight changes due to the presence or absence of SE and discontinuation (MAIN or STOP) of liraglutide were checked. RESULTS: Only 40.8% (64/157) of the patients remained on liraglutide for 6 months; 14.7% (23/157) maintained the drug despite SEs (MAIN_SE(+)), and 40.1% (63/157) discontinued the drug despite not having SEs (STOP_SE(-)). At 3 months, there was −5.9 ± 0.6%, −7.9 ± 0.9%, −4.5 ± 0.5%, and −3.4 ± 0.6% weight reduction in the MAIN_SE(-), MAIN_SE(+), STOP_SE(-), and STOP_SE(+) groups, respectively (all p < 0.001 compared to the baseline). However, there were no significant differences in the weight loss between the MAIN (p = 0.062) and STOP (p = 0.204) groups. At 6 months, the weight reduction was −2.0 ± 0.5% (p < 0.001) in MAIN_SE(-), −2.2 ± 0.7% (p < 0.005) in MAIN_SE(+), −1.7 ± 0.7% (p < 0.01) in STOP_SE(-), and −2.0 ± 0.6% (p = 0.01) in STOP_SE(+), compared to baseline. SEs also caused no significant differences in weight loss between the MAIN (p = 0.787) and STOP (p = 0.694) groups. CONCLUSIONS: Our study confirmed that the side effects of liraglutide did not affect weight reduction. Moreover, in the real world, the continuous rate of liraglutide use is not high, and the weight gradually increases after 3 months. Therefore, in addition to the side effects of liraglutide, the medical staff should consider various factors that affect drug adherence, consider ways to increase compliance, and continue to ensure management so that patients can maintain their weight.
format Online
Article
Text
id pubmed-9733986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-97339862022-12-19 A Study on Weight Loss Cause as per the Side Effect of Liraglutide Yu, Jin Lee, Jeongmin Lee, Seung-Hwan Cho, Jae-Hyung Kim, Hun-Sung Cardiovasc Ther Research Article PURPOSE: Liraglutide is known to have much lower weight loss effects in real clinical fields than in randomized clinical trials because of its side effects (SE) and discomfort associated with injections. This study is aimed at determining whether the side effects of liraglutide affect weight reduction and its maintenance in real-world practice. METHODS: Endocrinologists conducted a retrospective chart review of data from two tertiary university hospitals. All patients who had been prescribed liraglutide at least once between January 2014 and December 2019 were included. For an average of 3 and 6 months, weight changes due to the presence or absence of SE and discontinuation (MAIN or STOP) of liraglutide were checked. RESULTS: Only 40.8% (64/157) of the patients remained on liraglutide for 6 months; 14.7% (23/157) maintained the drug despite SEs (MAIN_SE(+)), and 40.1% (63/157) discontinued the drug despite not having SEs (STOP_SE(-)). At 3 months, there was −5.9 ± 0.6%, −7.9 ± 0.9%, −4.5 ± 0.5%, and −3.4 ± 0.6% weight reduction in the MAIN_SE(-), MAIN_SE(+), STOP_SE(-), and STOP_SE(+) groups, respectively (all p < 0.001 compared to the baseline). However, there were no significant differences in the weight loss between the MAIN (p = 0.062) and STOP (p = 0.204) groups. At 6 months, the weight reduction was −2.0 ± 0.5% (p < 0.001) in MAIN_SE(-), −2.2 ± 0.7% (p < 0.005) in MAIN_SE(+), −1.7 ± 0.7% (p < 0.01) in STOP_SE(-), and −2.0 ± 0.6% (p = 0.01) in STOP_SE(+), compared to baseline. SEs also caused no significant differences in weight loss between the MAIN (p = 0.787) and STOP (p = 0.694) groups. CONCLUSIONS: Our study confirmed that the side effects of liraglutide did not affect weight reduction. Moreover, in the real world, the continuous rate of liraglutide use is not high, and the weight gradually increases after 3 months. Therefore, in addition to the side effects of liraglutide, the medical staff should consider various factors that affect drug adherence, consider ways to increase compliance, and continue to ensure management so that patients can maintain their weight. Hindawi 2022-12-02 /pmc/articles/PMC9733986/ /pubmed/36540096 http://dx.doi.org/10.1155/2022/5201684 Text en Copyright © 2022 Jin Yu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yu, Jin
Lee, Jeongmin
Lee, Seung-Hwan
Cho, Jae-Hyung
Kim, Hun-Sung
A Study on Weight Loss Cause as per the Side Effect of Liraglutide
title A Study on Weight Loss Cause as per the Side Effect of Liraglutide
title_full A Study on Weight Loss Cause as per the Side Effect of Liraglutide
title_fullStr A Study on Weight Loss Cause as per the Side Effect of Liraglutide
title_full_unstemmed A Study on Weight Loss Cause as per the Side Effect of Liraglutide
title_short A Study on Weight Loss Cause as per the Side Effect of Liraglutide
title_sort study on weight loss cause as per the side effect of liraglutide
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733986/
https://www.ncbi.nlm.nih.gov/pubmed/36540096
http://dx.doi.org/10.1155/2022/5201684
work_keys_str_mv AT yujin astudyonweightlosscauseasperthesideeffectofliraglutide
AT leejeongmin astudyonweightlosscauseasperthesideeffectofliraglutide
AT leeseunghwan astudyonweightlosscauseasperthesideeffectofliraglutide
AT chojaehyung astudyonweightlosscauseasperthesideeffectofliraglutide
AT kimhunsung astudyonweightlosscauseasperthesideeffectofliraglutide
AT yujin studyonweightlosscauseasperthesideeffectofliraglutide
AT leejeongmin studyonweightlosscauseasperthesideeffectofliraglutide
AT leeseunghwan studyonweightlosscauseasperthesideeffectofliraglutide
AT chojaehyung studyonweightlosscauseasperthesideeffectofliraglutide
AT kimhunsung studyonweightlosscauseasperthesideeffectofliraglutide